Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Herpes zoster: Conundrums and controversies

World Congress on Infectious Diseases

Lorraine L. Rosamilia

Posters-Accepted Abstracts: J Infect Dis Ther

DOI: 10.4172/2332-0877.S1.003

Abstract

Herpes zoster presents significant clinical and fiscal morbidity for patients and providers. From acute and chronic wound
and pain conditions to vaccination strategies and infection control measures, its ramifications intertwine between many
medical disciplines and governing bodies.
A recent study of health care economic burden notes that herpes (including zoster) is one of the top 5 most costly categories
of skin disease. Moreover, medical providers differ widely in their approaches to the management of herpes zoster. For instance,
the literature wavers in its recommendations for prevention of post-herpetic neuralgia, yet a well-done recent study has shed
light on the effectiveness of antiviral and gabapentin regimens.
Also, vaccination strategies for herpes zoster are inconsistent. It is currently recommended in patients over 50, and very
few surveys have evaluated patient compliance since its FDA approval. In current clinical settings, it is unclear who should be
taking the lead (primary care vs. specialists) for its employment, despite its positive safety and efficacy profile.
In addition, hospital isolation policies for patients and staff with or exposed to herpes zoster are often inconsistent,
misunderstood, outdated, or poorly outlined in institutional handbooks. Furthermore, the difference in infectivity between
native varicella and subsequent herpes zoster is often misinterpreted.
A disease entity with such disparate management strategies should be clarified. By summarizing the pathogenesis of
herpes zoster and the efficacy of its treatment and vaccination, in addition to outlining the best practices given recent literature,
dermatologists, physician extenders, or and other medical providers will be better able to determine the appropriate course of
treatment, isolation measures, and education of zoster patients.

Biography

Lorraine L. Rosamilia is a Staff Dermatologist with the Geisinger Health System, practicing in State College, PA. She received medical school and residency
training in dermatology at the Penn State Milton S. Hershey Medical Center in Hershey, PA, and has particular interest in resident and primary care teaching and
scientific journal editing. Her practice focus includes medical dermatology, namely psoriasis, acne, infectious disease, and skin malignancy.

Top